Allworth Financial’s Medifast MED Stock Holding History

Allworth Financial’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.55K	Buy	523 +297	+131%	+$3.42K	﹤0.01%	4067
2026 Q1	$2.3K	Buy	226 +184	+438%	+$1.98K	﹤0.01%	4306
2025 Q4	$449	Sell	42 -51	-55%	-$610	﹤0.01%	4547
2025 Q3	$1.27K	Buy	93 +88	+1,760%	+$1.23K	﹤0.01%	4178
2025 Q2	$71	Buy	+5	New	+$66	﹤0.01%	4418
2024 Q1	–	Sell	-3	Closed	-$202	–	3653
2023 Q4	$202	Hold	3	–	–	﹤0.01%	3282
2023 Q3	$225	Sell	3 -6	-67%	-$532	﹤0.01%	3217
2023 Q2	$830	Hold	9	–	–	﹤0.01%	2788
2023 Q1	$934	Hold	9	–	–	﹤0.01%	2695
2022 Q4	$1.04K	Buy	9 +7	+350%	+$815	﹤0.01%	2460
2022 Q3	$0	Sell	2 -1	-33%	-$143	﹤0.01%	2922
2022 Q2	$1K	Buy	+3	New	+$537	﹤0.01%	2195

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Allworth Financial's MED Position: Q2 2026 in Review

Allworth Financial increased its Medifast (MED) stake by 131% in Q2 2026, buying an estimated $3.42K and bringing the position to 523 shares worth $5.55K. The position accounts for ﹤0.01% of the portfolio, ranked #4067.

Allworth Financial first reported a position in MED in Q2 2022 and has held it in 12 quarters since. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

Allworth Financial held 523 shares of Medifast worth $5.55K as of Q2 2026.
Allworth Financial bought 297 Medifast shares in Q2 2026, an estimated $3.42K.
Medifast made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4067 holding.
Allworth Financial first reported a position in Medifast in Q2 2022 and has held it in 12 quarters since.
113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.